CHAMGAP

Peer-led monthly lifestyle program × Reduced incidence by FPG alone

Select a review item to see its details.
Required evidence, verification status and materials actually read
ItemAVerification statusBReading scopeCReview itemDCurrent findingsEWhy unverifiedFRequired materials and conditionsGFurther research
1 Partly verified Full text not readStored summary read N01 · Evidence conditionSelected FPG question and original valuesRequired
The original FPG-only incidence-reduction subclaim is C. Parent D34 is context for the original prespecified composite-incidence verdict, not the subclaim score/axes.
Only the corresponding preserved-summary information is recorded; detailed originals remain unread and existing content review incomplete. Subclaim score, status and axes are absent; parent values are not inserted. Existing content review remains incomplete.
Selected subclaim grade/note, parent context and presence of score/status/axes
Proposal to link the original question scope to additional materials for updating; no new investigation, calculation or trial was performed.
2 Partly verified Full text not readStored summary read N02 · Evidence conditionHigh-risk adults without diabetes in KeralaRequired
The original population comprises 1,007 community residents aged 30-60 in Kerala, India, with IDRS at least 60 and no diabetes.
Only the corresponding preserved-summary information is recorded; detailed originals remain unread and existing content review incomplete. Baseline FPG/HbA1c, detailed eligibility/risk, group characteristics and the selected FPG denominator are unverified. Existing content review remains incomplete.
Population, recruitment criteria, baseline state and applicability
Proposal to examine applicability under the same population specification; no new investigation, calculation or trial was performed.
3 Partly verified Full text not readStored summary read N03 · Evidence conditionTrained peers and monthly group programRequired
The original intervention is a 12-month monthly group lifestyle program led by trained community peers. It is not replaced with a single activity or intensive expert-led intervention.
Only the corresponding preserved-summary information is recorded; detailed originals remain unread and existing content review incomplete. Education/session components, attendance, facilitator training, fidelity and actual individual exposure are unverified. Existing content review remains incomplete.
Intervention components, facilitators, intensity and actual delivery
Proposal to examine program components and actual delivery; no new investigation, calculation or trial was performed.
4 Partly verified Full text not readStored summary read N04 · Evidence conditionEducation-booklet controlRequired
Original allocation of 500 intervention participants and 507 education-booklet participants is retained. The control is not described as no action, no information or identical conditions.
Only the corresponding preserved-summary information is recorded; detailed originals remain unread and existing content review incomplete. Booklet content/use, other support/exposure and actual control participation are unverified. Existing content review remains incomplete.
Actual control and differences in accompanying exposure
Proposal to distinguish the actual intervention/control differences; no new investigation, calculation or trial was performed.
5 Partly verified Full text not readStored summary read N05 · Evidence condition12-month intervention and nine-year follow-upRequired
The monthly program lasted 12 months; nine-year outcomes are long-term follow-up of the same trial. Continued identical intervention throughout nine years is not assumed.
Only the corresponding preserved-summary information is recorded; detailed originals remain unread and existing content review incomplete. Individual attendance/exposure, subsequent activity/treatment, assessment windows and discontinuation/crossover are unverified. Existing content review remains incomplete.
Distinction between exposure duration and outcome follow-up
Proposal to examine exposure and long-term outcomes; no new investigation, calculation or trial was performed.
6 Partly verified Full text not readStored summary read N06 · Evidence conditionCluster allocation of 60 polling areasRequired
The original design cluster randomized 60 polling areas. Clusters, intervention/control groups and individuals are not counted as independent trials.
Only the corresponding preserved-summary information is recorded; detailed originals remain unread and existing content review incomplete. Allocation generation/concealment, stratification, cluster sizes, access rights and actual procedures are unread. Existing content review remains incomplete.
Cluster/individual units and allocation/concealment procedures
Proposal to examine cluster structure and population distribution; no new investigation, calculation or trial was performed.
7 Unverified Full text not readStored summary read N07 · Evidence conditionMasking and measurement rolesRequired
The stored cluster-intervention design is linked to test-based outcomes.
Currently required information is unverified in the preserved summary. Actual masking, test access and roles of participants/facilitators, laboratory staff/adjudicators and analysts are unverified. The design name alone does not certify absence of bias. Existing content review remains incomplete.
Role-specific procedures for incidence adjudication, testing and analysis
Proposal to examine measurement/adjudication bias; no new investigation, calculation or trial was performed.
8 Partly verified Full text not readStored summary read N08 · Evidence conditionFPG-only definition and testingRequired
The original account of a positive result using FPG alone is retained. All components/procedures of the prespecified composite definition are not automatically applied to this definition.
Only the corresponding preserved-summary information is recorded; detailed originals remain unread and existing content review incomplete. The selected FPG cutoff, fasting/testing, repeat confirmation, inclusion of physician diagnosis/medication and detailed event unit are unverified. Existing content review remains incomplete.
Selected incidence cutoff, testing/confirmation and event unit
Proposal to examine results under the definition/measurement specification; no new investigation, calculation or trial was performed.
9 Partly verified Full text not readStored summary read N09 · Evidence conditionFPG RR0.72·CI·PRequired
Original FPG-only RR 0.72 (95% CI 0.53-0.98), P=.036 is retained. No new risk difference, NNT or effect/CI is calculated.
Only the corresponding preserved-summary information is recorded; detailed originals remain unread and existing content review incomplete. Group-specific events/denominators, cluster adjustment, adjustment variables, estimation model and original output are unverified. Existing content review remains incomplete.
Selected between-group estimate, confidence interval and model
Proposal to examine precision for the same definition/estimate; no new investigation, calculation or trial was performed.
10 Partly verified Full text not readStored summary read N10 · Evidence conditionFPG events, denominators and timingRequired
The FPG-only result is linked to the nine-year discussion context. Composite-incidence 125/419 and 142/422 are not transferred to FPG events/denominators.
Only the corresponding preserved-summary information is recorded; detailed originals remain unread and existing content review incomplete. FPG group-specific event counts, denominators, assessment windows, cumulative/repeated events and omission/missingness handling are unverified. Existing content review remains incomplete.
Selected-definition analysis/observed denominator, events and time
Proposal to examine the same people and definition-specific outcomes; no new investigation, calculation or trial was performed.
11 Partly verified Full text not readStored summary read N11 · Evidence conditionPrespecified composite-incidence definitionRequired
The original prespecified primary definition is cumulative incidence based on FPG at least 126 mg/dL or HbA1c at least 6.5%, including physician diagnosis or initiation of glucose-lowering medication during follow-up. It is not replaced by FPG-only results.
Only the corresponding preserved-summary information is recorded; detailed originals remain unread and existing content review incomplete. Original component-specific events, overlap/confirmation procedures and planning/change history are unread. Existing content review remains incomplete.
Components/hierarchy of the prespecified primary definition and its relation to the selected definition
Proposal to distinguish definition/hierarchy and component-specific outcomes; no new investigation, calculation or trial was performed.
12 Partly verified Full text not readStored summary read N12 · Evidence conditionOriginal nine-year composite resultRequired
Prespecified nine-year composite 125/419 (30%) versus 142/422 (34%), RR 0.88 (0.73-1.08), P=.24 is retained as context. These are not the selected FPG events/estimate.
Only the corresponding preserved-summary information is recorded; detailed originals remain unread and existing content review incomplete. Correspondence of people/events across definitions and component-specific outcomes/denominators are unverified. No new difference, ratio or interaction is calculated. Existing content review remains incomplete.
Between-group outcomes under the other definition, distinguished from selected FPG
Proposal to distinguish definition-specific outcomes within the same cohort; no new investigation, calculation or trial was performed.
13 Partly verified Full text not readStored summary read N13 · Evidence conditionMultiple definitions, selection and multiplicityRequired
The original note that the positive FPG-only result was not the prespecified primary endpoint is retained. Selecting only the positive definition does not create an overall conclusion or new grade.
Only the corresponding preserved-summary information is recorded; detailed originals remain unread and existing content review incomplete. Definition list, prespecified hierarchy, multiplicity/adjustment, testing strategy and SAP are unread. Existing content review remains incomplete.
Prespecification of the selected positive result and multiplicity/overall-result specification
Proposal to examine selection/multiplicity and result interpretation; no new investigation, calculation or trial was performed.
14 Partly verified Full text not readStored summary read N14 · Evidence condition1,007·500/507·841Required
The 1,007 randomized participants (500/507) and 841 with nine-year outcome data (419/422) are retained separately. They are not described as full ITT or a verified identical denominator for selected FPG.
Only the corresponding preserved-summary information is recorded; detailed originals remain unread and existing content review incomplete. Group-specific inclusion/exclusion flow, FPG observation, death/withdrawal/missingness and cluster analysis are unverified. Existing content review remains incomplete.
Randomized population distinguished from the nine-year available-case analysis population
A follow-up research proposal on analysis populations and omission assumptions; no new investigation, calculation or trial is performed in this conversion.
15 Partly verified Full text not readStored summary read N15 · Evidence conditionLoss to follow-up: 144 and 14.3%Required
Original loss to follow-up of 144/1,007 (14.3%), below 15%, is retained. The separate 1,007 and 841 analysis accounts are not subtracted/reconciled to create new omission counts.
Only the corresponding preserved-summary information is recorded; detailed originals remain unread and existing content review incomplete. Stage-specific follow-up/analysis definitions, group-specific reasons, death/unmeasured exclusions and FPG missingness are unverified. Existing content review remains incomplete.
Original loss-to-follow-up account and its relation to available cases
Proposal to distinguish loss to follow-up from the actual analyzable population; no new investigation, calculation or trial was performed.
16 Partly verified Full text not readStored summary read N16 · Evidence conditionCluster analysis, missingness and sensitivityRequired
The original nine-year available-case account and cluster-randomized structure are retained.
Only the corresponding preserved-summary information is recorded; detailed originals remain unread and existing content review incomplete. Selected FPG cluster correlation, adjustment, missingness models, sensitivity and estimates for all randomized participants are unverified. No new model/effect is calculated. Existing content review remains incomplete.
Analysis specification for cluster adjustment, available cases and missingness assumptions
Proposal to examine uncertainty under cluster/missingness assumptions; no new investigation, calculation or trial was performed.
17 Partly verified Full text not readStored summary read N17 · Evidence conditionEarlier 24-month report of the same trialRequired
S02 is the same K-DPP trial’s earlier 24-month report. Its primary result is retained as 68/456 (14.9%) versus 79/463 (17.1%), RR 0.88 (0.66-1.16), P=.36. It does not become the nine-year FPG-only result or a separate independent trial.
Only the corresponding preserved-summary information is recorded; detailed originals remain unread and existing content review incomplete. Original 24-month definition, clusters/denominators, attrition/missingness, population correspondence to nine years and FPG-specific values are unverified. Existing content review remains incomplete.
Population, timing and results of the earlier report and relation to nine years
Follow-up proposal to distinguish time/definition-specific outcomes in the same cohort; no new investigation, calculation or trial was performed.
18 Partly verified Full text not readStored summary read N18 · Evidence conditionPaired registration identifiersRequired
Original ACTRN12611000262909 · CTRI/2021/10/037191 in the registration field is retained. The two identifiers are not counted as separate independent trials.
Only the corresponding preserved-summary information is recorded; detailed originals remain unread and existing content review incomplete. Each registration’s population/duration, prespecified plans, change history and relation to recruitment/analysis are unread. Existing content review remains incomplete.
Registration identity, scope of each identifier and original plans
Proposal to link prespecified plans and report/registration relationships; no new investigation, calculation or trial was performed.
19 Unverified Full text not readStored summary read N19 · Evidence conditionConcurrent activity, treatment and contaminationRequired
The monthly group-intervention/education-booklet difference is retained within its original scope.
Currently required information is unverified in the preserved summary. Group-specific diet/activity, expert support, testing/medication, external programs, contamination/crossover, actual adherence and subsequent exposure are unverified. No new lifestyle/treatment instructions are created. Existing content review remains incomplete.
Group-specific concurrent exposure, treatment/changes and actual participation
Proposal to examine concurrent exposure and attribution of program outcomes; no new investigation, calculation or trial was performed.
20 Partly verified Full text not readStored summary read N20 · Evidence conditionNHMRC funding and rolesRequired
The original account of support from the Australian National Health and Medical Research Council is retained.
Only the corresponding preserved-summary information is recorded; detailed originals remain unread and existing content review incomplete. Contracts, involvement in analysis/writing/publication, individual author relationships/COI and time-specific disclosures are unread. Public funding alone does not certify complete independence. Existing content review remains incomplete.
Funding provision distinguished from research/analysis/publication roles
Proposal to distinguish support roles and reporting relationships; no new investigation, calculation or trial was performed.
21 Partly verified Full text not readStored summary read N21 · Evidence conditionNo commercial product and other supportRequired
The original account that no commercial product was used is retained.
Only the corresponding preserved-summary information is recorded; detailed originals remain unread and existing content review incomplete. Product nonuse does not verify absence of all material/analysis/writing/publication-fee support, employee authors or COI. Individual disclosures are unread. Existing content review remains incomplete.
Commercial-product use distinguished from other support/relationships
Proposal to distinguish product/other support; no new investigation, calculation or trial was performed.
22 Partly verified Full text not readStored summary read N22 · Harm-information gaps supplementing the efficacy tableNine-year and 24-month safety-reporting scopeSupplementary
The original account is retained: no separate safety-outcome counts in the nine-year abstract, and no intervention-related adverse events reported at 24 months.
Only the corresponding preserved-summary information is recorded; detailed originals remain unread and existing content review incomplete. Actual harms collection, population/denominators, events, discontinuation and detailed nine-year originals are unread. Nonreporting/no related events does not establish zero long-term harms or certify safety. Existing content review remains incomplete.
Time-specific distinction between harms collection, reporting and denominators
Proposal to examine long-term follow-up and harms-reporting gaps; no new investigation, calculation or trial was performed.
23 Partly verified Full text not readStored summary read N23 · Evidence conditionIntensive expert programs and other evidenceRequired
Only the original context mentioning DPP/DPS and intensive expert-led intervention in 1531 is retained. These are not transferred as the same direct report for the monthly peer-led intervention/selected FPG.
Only the corresponding preserved-summary information is recorded; detailed originals remain unread and existing content review incomplete. Individual population, intervention, bibliography, estimates and direct correspondence for those trials are not linked in this source and remain unverified. Existing content review remains incomplete.
Intervention intensity/components and other trials’ identities/results
Proposal to distinguish intervention intensity/components and result applicability; no new investigation, calculation or trial was performed.
24 Partly verified Full text not readStored summary read N24 · Evidence conditionIndependence, follow-up reports and sibling sheetsRequired
Jeemon’s 2026 nine-year report and Thankappan’s 2018 24-month report are linked as reports of the same trial. Shared 60 clusters, people/groups, definitions, time points and sibling sheets are not added as new independent trials/participants.
Only the corresponding preserved-summary information is recorded; detailed originals remain unread and existing content review incomplete. Actual people/cluster/time correspondence, unique participants and independent replication have not been checked against external materials. Original R1 is not inherited as new independence certification. Existing content review remains incomplete.
Relationships among reports, trials, people, time points and definitions
Proposal to distinguish the same trial from separate evidence; no new investigation, calculation or trial was performed.
25 Partly verified Full text not readStored summary read N25 · Evidence conditionNine years and other durations/populationsRequired
The selected positive result concerns the FPG-only definition for a low-cost peer-led program. It is not extended to preventive efficacy or ineffectiveness across all definitions, intensive expert-led interventions or other populations.
Only the corresponding preserved-summary information is recorded; detailed originals remain unread and existing content review incomplete. Other recruitment criteria, eras, intensity/duration, long-term clinical outcomes/harms and definition-specific correspondence are unverified. Existing content review remains incomplete.
Other populations, durations/intensity and long-term follow-up beyond this question
Proposal to distinguish the selected question from other conditions; no new investigation, calculation or trial was performed.
26 Partly verified Full text not readStored summary read N26 · Evidence conditionOriginal axes, Korean/English text, dates and correctionsRequired
Subclaim C/note, parent D34, B/H/R1/I2/E0/B1/C0, false/true/false flags, empty overrides, Korean/English, 2026-08-26 and empty corrections/deliberation are preserved in the complete original summary.
Only the corresponding preserved-summary information is recorded; detailed originals remain unread and existing content review incomplete. Historical cross-checking/research accounts are not current review, original-paper reading or fulfillment of new conditions. Absent subclaim score/status/axes and parent facets keys are not filled. Existing content review remains incomplete.
Distinction between original subclaim and parent values, original reference date and correction/history
Updating proposal to distinguish changes to original materials from preparation versions; no new investigation, calculation or trial was performed.
27 Partly verified Full text not readStored summary read N27 · Evidence conditionActual summary reading and unread external materialsRequired
The preserved JSON summary was read for preparation, linking nine-year/24-month bibliographies and URLs. External papers, registration, protocol/SAP and funding/COI originals remain unread, with no access attempted.
Only the corresponding preserved-summary information is recorded; detailed originals remain unread and existing content review incomplete. Bibliographic links or registration identifiers do not upgrade acquisition/reading/review status. No external click/link checks were performed in this preparation. Existing content review remains incomplete.
Actual reading by material, bibliography/URLs and additional-material gaps
A research proposal for scope-specific updates based on actually acquired material; no new investigation, calculation or trial is performed in this conversion.
No items match your search or filter.

27 itemsWhat the statuses mean

Assessment scope

Stored-material review date
Not recorded
Original evidence cut-off
2026-08-26
Scope actually checked
Existing review summaries and stored records of methodological application. Full papers, supplements, registrations, plans and original data were not read.
What the dates mean
This is the date the stored materials were checked, not the date of a new search of the clinical literature.
Population
Community residents aged 30-60 in 60 polling areas in Kerala, India, with IDRS at least 60 and no diabetes. The 1,007 randomized (500/507), 841 nine-year available cases (419/422) and original loss-to-follow-up account of 144/1,007 (14.3%) are retained separately. Exact FPG-only events/denominators, baseline/observation/missingness and stage-specific population flow are unverified; no subtraction or new totals are calculated.
Ingredient, formulation and route
A 12-month monthly group lifestyle program led by trained community peers. Actual components, intensity, attendance/adherence and subsequent exposure are unverified. It is not recast as the effect of a single activity or intensive expert-led intervention, or as new lifestyle/prevention/treatment instructions.
Dose
The monthly 12-month intervention is distinguished from nine-year/24-month outcome follow-up. Continued identical intervention/exposure throughout nine years is not assumed. Actual individual timing/attendance/changes and other intensities/durations remain unverified.
Comparator
Cluster-randomized comparison of education booklet for 507 participants versus monthly program for 500. Actual control use, other support/exposure, allocation/masking, cluster adjustment/contamination and concurrent treatment/activity are unverified. Education booklet is not relabeled as no action.
Measured outcome
Selected FPG-only RR 0.72 (95% CI 0.53-0.98), P=.036 and the original note that it was not the prespecified primary endpoint are retained. Exact cutoff, testing/confirmation, group events/denominators, model and multiplicity are unverified. Prespecified nine-year composite FPG at least 126 mg/dL or HbA1c at least 6.5%, including physician diagnosis/starting glucose-lowering medication, and 125/419 (30%) versus 142/422 (34%), RR 0.88 (0.73-1.08), P=.24 are different results. The two definitions are not assigned identical events/denominators.
Duration
The selected positive FPG result belongs to the nine-year discussion context and is distinguished from 12-month intervention exposure. Same-trial 24-month primary 68/456 (14.9%) versus 79/463 (17.1%), RR 0.88 (0.66-1.16), P=.36 is a preserved report at another time/definition. Actual selected FPG assessment window, cumulative/repeated events and subsequent follow-up are unverified.
Questions outside this scope
Upgrade FPG-only RR 0.72/P=.036 to the prespecified composite primary conclusion or efficacy across all definitions/intensive expert-led programs; Reuse composite nine-year/24-month primary events, denominators, cutoffs or components as verified selected FPG values; Subtract/reconcile original 1,007, 841 and 144 recruitment/analysis/follow-up accounts to calculate new omission counts or event proportions; Add 60 clusters, shared people/groups, times/definitions, two reports/registrations or sibling sheets as new independent trials/participants; Convert public funding/nonuse of commercial products into absence of individual support/COI or new independence certification; Convert missing nine-year safety counts/no related adverse events at 24 months into zero harms or confirmed long-term safety; Inheriting parent scores/axes, historical cross-checks or registration descriptions as subclaim scores, current verification or external reading; New calculations, invented values, effects/confidence intervals, grades, independence certification or instructions for lifestyle, product intake, testing or treatment

Evidence and sources

The links below lead to the sources. A link alone does not mean the original source was read or its latest publication status verified.

S01 · Jeemon P et al. 2026 K-DPP nine-year follow-up

PubMed

Material type
Long-term follow-up of a 60-cluster randomized controlled trial
Materials actually read
Summary read; external material unread
Findings recorded in the stored summary
Selected FPG-only RR 0.72 (95% CI 0.53-0.98), P=.036 retains the original note that this was not the prespecified primary definition. Prespecified nine-year composite results are 125/419 (30%) versus 142/422 (34%), RR 0.88 (95% CI 0.73-1.08), P=.24 under a different definition/estimate. FPG group-specific events/denominators, exact testing/hierarchy and original analysis are unverified.
Record level
Outcome wording in the stored summary
Study overlap and independent replication
S01 Jeemon’s 2026 nine-year and S02 Thankappan’s 2018 24-month reports concern the same K-DPP cluster trial. In 60 polling areas in Kerala, India, 1,007 participants aged 30-60 with IDRS at least 60 and no diabetes (500/507) were assigned to a 12-month monthly peer-led program or education booklet. Nine-year available cases of 841 (419/422) and original loss to follow-up of 144/1,007 (14.3%) are separate accounts; no subtraction or new denominators are calculated. Selected FPG-only RR 0.72 (0.53-0.98), P=.036 and the nonprimary note are distinguished from prespecified nine-year composite 125/419 (30%) versus 142/422 (34%), RR 0.88 (0.73-1.08), P=.24, and 24-month primary 68/456 (14.9%) versus 79/463 (17.1%), RR 0.88 (0.66-1.16), P=.36. FPG-only events/denominators, exact definition/testing/hierarchy, cluster/missingness handling and actual population correspondence are unverified. Shared clusters, people/groups, times/definitions, reports/registrations and sibling sheets are not new independent trials/participants. Report/material slot counts are not totals of unique clinical trials, participants or independent replications; no new totals or independence certification are made.
Public availability, access and reading status by material
MaterialPublic availabilityAccess statusActually readNotes
Stored summaryStored fileStored summarySummary readOnly stored-summary and bibliographic content was used for production. External material verification/review is not complete.
External paperPublic availability unverified; only bibliography links preservedUnread; access not attemptedNot readNo external access or click testing was performed in the original preparation. URLs or registration identifiers alone do not upgrade acquisition/reading status.
Registration materialPublic availability unverified; only bibliography links preservedUnread; access not attemptedNot readNo external access or click testing was performed in the original preparation. URLs or registration identifiers alone do not upgrade acquisition/reading status.
ProtocolPublic availability unverified; only bibliography links preservedUnread; access not attemptedNot readNo external access or click testing was performed in the original preparation. URLs or registration identifiers alone do not upgrade acquisition/reading status.
Statistical analysis planPublic availability unverified; only bibliography links preservedUnread; access not attemptedNot readNo external access or click testing was performed in the original preparation. URLs or registration identifiers alone do not upgrade acquisition/reading status.
Funding, product-support and COI materialPublic availability unverified; only bibliography links preservedUnread; access not attemptedNot readNo external access or click testing was performed in the original preparation. URLs or registration identifiers alone do not upgrade acquisition/reading status.

S02 · Thankappan KR, et al. A peer-support lifestyle intervention to prevent type 2 diabetes in India: a cluster-randomized controlled trial. Diabetes Care. 2018. PMID: 29874236.

PubMed

Material type
Earlier 24-month report of the same cluster trial · Preserved original cross-citation
Materials actually read
Summary read; external material unread
Findings recorded in the stored summary
The same trial’s 24-month primary 68/456 (14.9%) versus 79/463 (17.1%), RR 0.88 (95% CI 0.66-1.16), P=.36 is linked through preserved Korean/English and the citation’s one-line account. It is not the nine-year FPG-only result/denominator; there is no existing native evidence-list entry for this report.
Record level
Outcome wording in the stored summary
Study overlap and independent replication
S01 Jeemon’s 2026 nine-year and S02 Thankappan’s 2018 24-month reports concern the same K-DPP cluster trial. In 60 polling areas in Kerala, India, 1,007 participants aged 30-60 with IDRS at least 60 and no diabetes (500/507) were assigned to a 12-month monthly peer-led program or education booklet. Nine-year available cases of 841 (419/422) and original loss to follow-up of 144/1,007 (14.3%) are separate accounts; no subtraction or new denominators are calculated. Selected FPG-only RR 0.72 (0.53-0.98), P=.036 and the nonprimary note are distinguished from prespecified nine-year composite 125/419 (30%) versus 142/422 (34%), RR 0.88 (0.73-1.08), P=.24, and 24-month primary 68/456 (14.9%) versus 79/463 (17.1%), RR 0.88 (0.66-1.16), P=.36. FPG-only events/denominators, exact definition/testing/hierarchy, cluster/missingness handling and actual population correspondence are unverified. Shared clusters, people/groups, times/definitions, reports/registrations and sibling sheets are not new independent trials/participants. Report/material slot counts are not totals of unique clinical trials, participants or independent replications; no new totals or independence certification are made.
Public availability, access and reading status by material
MaterialPublic availabilityAccess statusActually readNotes
Stored summaryStored fileStored summarySummary readOnly stored-summary and bibliographic content was used for production. External material verification/review is not complete.
External paperPublic availability unverified; only bibliography links preservedUnread; access not attemptedNot readNo external access or click testing was performed in the original preparation. URLs or registration identifiers alone do not upgrade acquisition/reading status.
Registration materialPublic availability unverified; only bibliography links preservedUnread; access not attemptedNot readNo external access or click testing was performed in the original preparation. URLs or registration identifiers alone do not upgrade acquisition/reading status.
ProtocolPublic availability unverified; only bibliography links preservedUnread; access not attemptedNot readNo external access or click testing was performed in the original preparation. URLs or registration identifiers alone do not upgrade acquisition/reading status.
Statistical analysis planPublic availability unverified; only bibliography links preservedUnread; access not attemptedNot readNo external access or click testing was performed in the original preparation. URLs or registration identifiers alone do not upgrade acquisition/reading status.
Funding, product-support and COI materialPublic availability unverified; only bibliography links preservedUnread; access not attemptedNot readNo external access or click testing was performed in the original preparation. URLs or registration identifiers alone do not upgrade acquisition/reading status.

Report counts versus independent study counts

S01 Jeemon’s 2026 nine-year and S02 Thankappan’s 2018 24-month reports concern the same K-DPP cluster trial. In 60 polling areas in Kerala, India, 1,007 participants aged 30-60 with IDRS at least 60 and no diabetes (500/507) were assigned to a 12-month monthly peer-led program or education booklet. Nine-year available cases of 841 (419/422) and original loss to follow-up of 144/1,007 (14.3%) are separate accounts; no subtraction or new denominators are calculated. Selected FPG-only RR 0.72 (0.53-0.98), P=.036 and the nonprimary note are distinguished from prespecified nine-year composite 125/419 (30%) versus 142/422 (34%), RR 0.88 (0.73-1.08), P=.24, and 24-month primary 68/456 (14.9%) versus 79/463 (17.1%), RR 0.88 (0.66-1.16), P=.36. FPG-only events/denominators, exact definition/testing/hierarchy, cluster/missingness handling and actual population correspondence are unverified. Shared clusters, people/groups, times/definitions, reports/registrations and sibling sheets are not new independent trials/participants. Report/material slot counts are not totals of unique clinical trials, participants or independent replications; no new totals or independence certification are made.

Review criteria

Version 1.0 · Criteria record date 2026-10-06. These are Chamgap's own application conditions, informed by the referenced methods. They do not constitute official assessment-tool certification or a new efficacy score.

N01 · Selected FPG question and original values
Required materials and conditions
Selected subclaim grade/note, parent context and presence of score/status/axes
Conditions for verification
Corresponding original materials and analysis scope for Selected subclaim grade/note, parent context and presence of score/status/axes must be supplied so unverified matters can be distinguished. Preserved wording is linked here; existing content review remains incomplete.
Requirement and applicability
Required
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Why this condition is needed
Preparation item distinguishing Selected subclaim grade/note, parent context and presence of score/status/axes to link required and current materials for the selected question.
Referenced methods
M03 §3.1, §3.2.1–3.2.4 question-clarification principles; detailed separation rules are custom design; M03 §3.2.4, M15 §15.3.1–15.3.3; question-specific outcome adaptation is custom design; M04 §4.5, §4.6.3; limits on current material conversion reflect the review scope and custom design
N02 · High-risk adults without diabetes in Kerala
Required materials and conditions
Population, recruitment criteria, baseline state and applicability
Conditions for verification
Corresponding original materials and analysis scope for Population, recruitment criteria, baseline state and applicability must be supplied so unverified matters can be distinguished. Preserved wording is linked here; existing content review remains incomplete.
Requirement and applicability
Required
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Why this condition is needed
Preparation item distinguishing Population, recruitment criteria, baseline state and applicability to link required and current materials for the selected question.
Referenced methods
M03 §3.2.1; detailed population conditions are custom design; M03 §3.2.1–3.2.4; dose/duration/effect-modification details are custom design; M08 Table 8.2.a, M15 §15.3, M19 §19.1.2–19.2.4; design-specific adaptation is custom design
N03 · Trained peers and monthly group program
Required materials and conditions
Intervention components, facilitators, intensity and actual delivery
Conditions for verification
Corresponding original materials and analysis scope for Intervention components, facilitators, intensity and actual delivery must be supplied so unverified matters can be distinguished. Preserved wording is linked here; existing content review remains incomplete.
Requirement and applicability
Required
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Why this condition is needed
Preparation item distinguishing Intervention components, facilitators, intensity and actual delivery to link required and current materials for the selected question.
Referenced methods
M03 §3.2.2–3.2.3; reverse-direction labels and checking adaptations are internally designed; M03 §3.2.3, M08 §8.2.2–8.2.3; internal application; M03 §3.2.1–3.2.4; dose, duration and effect-modification details are internally designed
N04 · Education-booklet control
Required materials and conditions
Actual control and differences in accompanying exposure
Conditions for verification
Corresponding original materials and analysis scope for Actual control and differences in accompanying exposure must be supplied so unverified matters can be distinguished. Preserved wording is linked here; existing content review remains incomplete.
Requirement and applicability
Required
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Why this condition is needed
Preparation item distinguishing Actual control and differences in accompanying exposure to link required and current materials for the selected question.
Referenced methods
M03 §3.2.2–3.2.3; Reverse labels and test adaptations are designed by CHAMGAP; M03 §3.2.3, M08 §8.2.2–8.2.3; CHAMGAP adaptation; M04 §4.6.3, M15 §15.3.1–15.3.3; Status distinctions are designed by CHAMGAP
N05 · 12-month intervention and nine-year follow-up
Required materials and conditions
Distinction between exposure duration and outcome follow-up
Conditions for verification
Corresponding original materials and analysis scope for Distinction between exposure duration and outcome follow-up must be supplied so unverified matters can be distinguished. Preserved wording is linked here; existing content review remains incomplete.
Requirement and applicability
Required
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Why this condition is needed
Preparation item distinguishing Distinction between exposure duration and outcome follow-up to link required and current materials for the selected question.
Referenced methods
M03 §3.2.4 and M15 §§15.3.1–15.3.3; question-specific outcome adaptation is Chamgap-designed; M03 §3.2.3 and M08 §§8.2.2–8.2.3; Chamgap adaptation; M03 §§3.2.1–3.2.4; dose, durability and effect-modification details are Chamgap-designed
N06 · Cluster allocation of 60 polling areas
Required materials and conditions
Cluster/individual units and allocation/concealment procedures
Conditions for verification
Corresponding original materials and analysis scope for Cluster/individual units and allocation/concealment procedures must be supplied so unverified matters can be distinguished. Preserved wording is linked here; existing content review remains incomplete.
Requirement and applicability
Required
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Why this condition is needed
Preparation item distinguishing Cluster/individual units and allocation/concealment procedures to link required and current materials for the selected question.
Referenced methods
M08 §8.1–8.2.3; CHAMGAP adaptation; Distinction between studies and reports in M04 §4.6.1–4.6.2; Cohort/outcome connections are CHAMGAP adaptations; M08 Table 8.2.a, M15 §15.3, M19 §19.1.2–19.2.4; Design-specific adaptations are designed by CHAMGAP; Material collection/selection principles in M04 §4.5–4.6; Separating access from reading and defining hyperlink behavior are designed by CHAMGAP
N07 · Masking and measurement roles
Required materials and conditions
Role-specific procedures for incidence adjudication, testing and analysis
Conditions for verification
Corresponding original materials and analysis scope for Role-specific procedures for incidence adjudication, testing and analysis must be supplied so unverified matters can be distinguished. Preserved wording is linked here; existing content review remains incomplete.
Requirement and applicability
Required
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Why this condition is needed
Preparation item distinguishing Role-specific procedures for incidence adjudication, testing and analysis to link required and current materials for the selected question.
Referenced methods
M08 Table 8.2.a, M03 §3.2.4; CHAMGAP adaptation; Material collection/selection principles in M04 §4.5–4.6; Separating access from reading and defining hyperlink behavior are designed by CHAMGAP
N08 · FPG-only definition and testing
Required materials and conditions
Selected incidence cutoff, testing/confirmation and event unit
Conditions for verification
Corresponding original materials and analysis scope for Selected incidence cutoff, testing/confirmation and event unit must be supplied so unverified matters can be distinguished. Preserved wording is linked here; existing content review remains incomplete.
Requirement and applicability
Required
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Why this condition is needed
Preparation item distinguishing Selected incidence cutoff, testing/confirmation and event unit to link required and current materials for the selected question.
Referenced methods
M03 §3.2.4, M15 §15.3.1–15.3.3; outcome adaptation to each question is internally designed; M08 Table 8.2.a, M03 §3.2.4; internal application; M08 Table 8.2.a, M04 §4.6.3; internal application
N09 · FPG RR0.72·CI·P
Required materials and conditions
Selected between-group estimate, confidence interval and model
Conditions for verification
Corresponding original materials and analysis scope for Selected between-group estimate, confidence interval and model must be supplied so unverified matters can be distinguished. Preserved wording is linked here; existing content review remains incomplete.
Requirement and applicability
Required
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Why this condition is needed
Preparation item distinguishing Selected between-group estimate, confidence interval and model to link required and current materials for the selected question.
Referenced methods
M15 §15.3.1–15.3.3; CHAMGAP adaptation; M08 §8.2.2, M15 §15.3.1; CHAMGAP adaptation; M08 Table 8.2.a, M15 §15.3, M19 §19.1.2–19.2.4; Design-specific adaptations are designed by CHAMGAP
N10 · FPG events, denominators and timing
Required materials and conditions
Selected-definition analysis/observed denominator, events and time
Conditions for verification
Corresponding original materials and analysis scope for Selected-definition analysis/observed denominator, events and time must be supplied so unverified matters can be distinguished. Preserved wording is linked here; existing content review remains incomplete.
Requirement and applicability
Required
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Why this condition is needed
Preparation item distinguishing Selected-definition analysis/observed denominator, events and time to link required and current materials for the selected question.
Referenced methods
M08 Table 8.2.a, M15 §15.3, M19 §19.1.2–19.2.4; Design-specific adaptations are designed by CHAMGAP; M03 §3.2.4, M15 §15.3.1–15.3.3; Question-specific outcome adaptations are designed by CHAMGAP; M08 §8.2.2, M15 §15.3.1; CHAMGAP adaptation; Distinction between studies and reports in M04 §4.6.1–4.6.2; Cohort/outcome connections are CHAMGAP adaptations
N11 · Prespecified composite-incidence definition
Required materials and conditions
Components/hierarchy of the prespecified primary definition and its relation to the selected definition
Conditions for verification
Corresponding original materials and analysis scope for Components/hierarchy of the prespecified primary definition and its relation to the selected definition must be supplied so unverified matters can be distinguished. Preserved wording is linked here; existing content review remains incomplete.
Requirement and applicability
Required
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Why this condition is needed
Preparation item distinguishing Components/hierarchy of the prespecified primary definition and its relation to the selected definition to link required and current materials for the selected question.
Referenced methods
M08 Table 8.2.a, M04 §4.6.3; CHAMGAP adaptation; M03 §3.2.4, M15 §15.3.1–15.3.3; Question-specific outcome adaptations are designed by CHAMGAP; M08 Table 8.2.a, M03 §3.2.4; CHAMGAP adaptation; M04 §4.6.3, M15 §15.3.1–15.3.3; Status distinctions are designed by CHAMGAP
N12 · Original nine-year composite result
Required materials and conditions
Between-group outcomes under the other definition, distinguished from selected FPG
Conditions for verification
Corresponding original materials and analysis scope for Between-group outcomes under the other definition, distinguished from selected FPG must be supplied so unverified matters can be distinguished. Preserved wording is linked here; existing content review remains incomplete.
Requirement and applicability
Required
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Why this condition is needed
Preparation item distinguishing Between-group outcomes under the other definition, distinguished from selected FPG to link required and current materials for the selected question.
Referenced methods
M04 §4.6.3, M15 §15.3.1–15.3.3; Status distinctions are designed by CHAMGAP; M03 §3.2.4, M15 §15.3.1–15.3.3; Question-specific outcome adaptations are designed by CHAMGAP; M15 §15.3.1–15.3.3; CHAMGAP adaptation; Distinction between studies and reports in M04 §4.6.1–4.6.2; Cohort/outcome connections are CHAMGAP adaptations
N13 · Multiple definitions, selection and multiplicity
Required materials and conditions
Prespecification of the selected positive result and multiplicity/overall-result specification
Conditions for verification
Corresponding original materials and analysis scope for Prespecification of the selected positive result and multiplicity/overall-result specification must be supplied so unverified matters can be distinguished. Preserved wording is linked here; existing content review remains incomplete.
Requirement and applicability
Required
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Why this condition is needed
Preparation item distinguishing Prespecification of the selected positive result and multiplicity/overall-result specification to link required and current materials for the selected question.
Referenced methods
M08 Table 8.2.a, M04 §4.6.3; CHAMGAP adaptation; M04 §4.6.3, M15 §15.3.1–15.3.3; Status distinctions are designed by CHAMGAP; M15 §15.3.1–15.3.3; CHAMGAP adaptation
N14 · 1,007·500/507·841
Required materials and conditions
Randomized population distinguished from the nine-year available-case analysis population
Conditions for verification
Corresponding original materials and analysis scope for Randomized population distinguished from the nine-year available-case analysis population must be supplied so unverified matters can be distinguished. Preserved wording is linked here; existing content review remains incomplete.
Requirement and applicability
Required
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Why this condition is needed
Preparation item distinguishing Randomized population distinguished from the nine-year available-case analysis population to link required and current materials for the selected question.
Referenced methods
M08 Table 8.2.a, M15 §15.3, M19 §19.1.2–19.2.4; design-specific adaptation is custom design; M08 §8.2.2, M15 §15.3.1; custom application; M04 §4.6.1–4.6.2 distinction between studies and reports; cohort/outcome linkage is a custom application
N15 · Loss to follow-up: 144 and 14.3%
Required materials and conditions
Original loss-to-follow-up account and its relation to available cases
Conditions for verification
Corresponding original materials and analysis scope for Original loss-to-follow-up account and its relation to available cases must be supplied so unverified matters can be distinguished. Preserved wording is linked here; existing content review remains incomplete.
Requirement and applicability
Required
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Why this condition is needed
Preparation item distinguishing Original loss-to-follow-up account and its relation to available cases to link required and current materials for the selected question.
Referenced methods
M08 Table 8.2.a, M15 §15.3, M19 §19.1.2–19.2.4; Design-specific adaptations are designed by CHAMGAP; M08 §8.2.2, M15 §15.3.1; CHAMGAP adaptation; Material collection/selection principles in M04 §4.5–4.6; Separating access from reading and defining hyperlink behavior are designed by CHAMGAP
N16 · Cluster analysis, missingness and sensitivity
Required materials and conditions
Analysis specification for cluster adjustment, available cases and missingness assumptions
Conditions for verification
Corresponding original materials and analysis scope for Analysis specification for cluster adjustment, available cases and missingness assumptions must be supplied so unverified matters can be distinguished. Preserved wording is linked here; existing content review remains incomplete.
Requirement and applicability
Required
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Why this condition is needed
Preparation item distinguishing Analysis specification for cluster adjustment, available cases and missingness assumptions to link required and current materials for the selected question.
Referenced methods
M08 §8.2.2, M15 §15.3.1; custom application; M08 Table 8.2.a, M15 §15.3, M19 §19.1.2–19.2.4; design-specific adaptation is custom design; M15 §15.3.1–15.3.3; custom application
N17 · Earlier 24-month report of the same trial
Required materials and conditions
Population, timing and results of the earlier report and relation to nine years
Conditions for verification
Corresponding original materials and analysis scope for Population, timing and results of the earlier report and relation to nine years must be supplied so unverified matters can be distinguished. Preserved wording is linked here; existing content review remains incomplete.
Requirement and applicability
Required
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Why this condition is needed
Preparation item distinguishing Population, timing and results of the earlier report and relation to nine years to link required and current materials for the selected question.
Referenced methods
Distinction between studies and reports in M04 §4.6.1–4.6.2; Cohort/outcome connections are CHAMGAP adaptations; M03 §3.2.4, M15 §15.3.1–15.3.3; Question-specific outcome adaptations are designed by CHAMGAP; M04 §4.6.3, M15 §15.3.1–15.3.3; Status distinctions are designed by CHAMGAP; M08 §8.2.2, M15 §15.3.1; CHAMGAP adaptation
N18 · Paired registration identifiers
Required materials and conditions
Registration identity, scope of each identifier and original plans
Conditions for verification
Corresponding original materials and analysis scope for Registration identity, scope of each identifier and original plans must be supplied so unverified matters can be distinguished. Preserved wording is linked here; existing content review remains incomplete.
Requirement and applicability
Required
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Why this condition is needed
Preparation item distinguishing Registration identity, scope of each identifier and original plans to link required and current materials for the selected question.
Referenced methods
M08 Table 8.2.a, M04 §4.6.3; CHAMGAP adaptation; Material collection/selection principles in M04 §4.5–4.6; Separating access from reading and defining hyperlink behavior are designed by CHAMGAP; Distinction between studies and reports in M04 §4.6.1–4.6.2; Cohort/outcome connections are CHAMGAP adaptations
N19 · Concurrent activity, treatment and contamination
Required materials and conditions
Group-specific concurrent exposure, treatment/changes and actual participation
Conditions for verification
Corresponding original materials and analysis scope for Group-specific concurrent exposure, treatment/changes and actual participation must be supplied so unverified matters can be distinguished. Preserved wording is linked here; existing content review remains incomplete.
Requirement and applicability
Required
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Why this condition is needed
Preparation item distinguishing Group-specific concurrent exposure, treatment/changes and actual participation to link required and current materials for the selected question.
Referenced methods
M03 §3.2.3, M08 §8.2.2–8.2.3; custom application; M03 §3.2.2–3.2.3; reverse-direction labeling and test adaptation are custom design; M03 §3.2.1–3.2.4; dose/duration/effect-modification details are custom design
N20 · NHMRC funding and roles
Required materials and conditions
Funding provision distinguished from research/analysis/publication roles
Conditions for verification
Corresponding original materials and analysis scope for Funding provision distinguished from research/analysis/publication roles must be supplied so unverified matters can be distinguished. Preserved wording is linked here; existing content review remains incomplete.
Requirement and applicability
Required
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Why this condition is needed
Preparation item distinguishing Funding provision distinguished from research/analysis/publication roles to link required and current materials for the selected question.
Referenced methods
Chamgap independence/attribution conditions. The referenced official method sections do not certify every detail of these items; Data collection/selection principles in M04 §4.5–4.6; Access/reading separation and hyperlink rules are Chamgap design
N21 · No commercial product and other support
Required materials and conditions
Commercial-product use distinguished from other support/relationships
Conditions for verification
Corresponding original materials and analysis scope for Commercial-product use distinguished from other support/relationships must be supplied so unverified matters can be distinguished. Preserved wording is linked here; existing content review remains incomplete.
Requirement and applicability
Required
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Why this condition is needed
Preparation item distinguishing Commercial-product use distinguished from other support/relationships to link required and current materials for the selected question.
Referenced methods
Chamgap independence/attribution conditions. The referenced official method sections do not certify every detail of these items; Data collection/selection principles in M04 §4.5–4.6; Access/reading separation and hyperlink rules are Chamgap design
N22 · Nine-year and 24-month safety-reporting scope
Required materials and conditions
Time-specific distinction between harms collection, reporting and denominators
Conditions for verification
Corresponding original materials and analysis scope for Time-specific distinction between harms collection, reporting and denominators must be supplied so unverified matters can be distinguished. Preserved wording is linked here; existing content review remains incomplete.
Requirement and applicability
Supplementary
Application exceptions
Supplements the selected subclaim’s safety-material gap. Incidence results or parent safety wording do not establish safety or generate harm rates or new usage instructions.
Why this condition is needed
Preparation item distinguishing Time-specific distinction between harms collection, reporting and denominators to link required and current materials for the selected question.
Referenced methods
M19 §19.1.2–19.2.4; detailed distinctions are Chamgap’s own design; M19 §19.1.2–19.2.4; Chamgap application; M19 §19.1.2–19.2.4; Chamgap application; M19 §19.1.2–19.2.4; Chamgap application
N23 · Intensive expert programs and other evidence
Required materials and conditions
Intervention intensity/components and other trials’ identities/results
Conditions for verification
Corresponding original materials and analysis scope for Intervention intensity/components and other trials’ identities/results must be supplied so unverified matters can be distinguished. Preserved wording is linked here; existing content review remains incomplete.
Requirement and applicability
Required
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Why this condition is needed
Preparation item distinguishing Intervention intensity/components and other trials’ identities/results to link required and current materials for the selected question.
Referenced methods
M04 §4.6.3, M15 §15.3.1–15.3.3; Status distinctions are designed by CHAMGAP; M03 §3.2.2–3.2.3; Reverse labels and test adaptations are designed by CHAMGAP; M03 §3.2.1–3.2.4; Dose, duration and effect-modification details are designed by CHAMGAP; Distinction between studies and reports in M04 §4.6.1–4.6.2; Cohort/outcome connections are CHAMGAP adaptations
N24 · Independence, follow-up reports and sibling sheets
Required materials and conditions
Relationships among reports, trials, people, time points and definitions
Conditions for verification
Corresponding original materials and analysis scope for Relationships among reports, trials, people, time points and definitions must be supplied so unverified matters can be distinguished. Preserved wording is linked here; existing content review remains incomplete.
Requirement and applicability
Required
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Why this condition is needed
Preparation item distinguishing Relationships among reports, trials, people, time points and definitions to link required and current materials for the selected question.
Referenced methods
M04 §4.6.1–4.6.2 distinction between studies and reports; cohort/outcome linkage is a custom application; M04 §4.6.1–4.6.2, M15 §15.3.1; custom application; M04 §4.5, §4.6.3; limits on current material conversion reflect the review scope and custom design
N25 · Nine years and other durations/populations
Required materials and conditions
Other populations, durations/intensity and long-term follow-up beyond this question
Conditions for verification
Corresponding original materials and analysis scope for Other populations, durations/intensity and long-term follow-up beyond this question must be supplied so unverified matters can be distinguished. Preserved wording is linked here; existing content review remains incomplete.
Requirement and applicability
Required
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Why this condition is needed
Preparation item distinguishing Other populations, durations/intensity and long-term follow-up beyond this question to link required and current materials for the selected question.
Referenced methods
M03 §3.2.1–3.2.4; Dose, duration and effect-modification details are designed by CHAMGAP; M03 §3.2.4; CHAMGAP’s boundary for extensions; M03 §3.2.1; Detailed population criteria are designed by CHAMGAP; M03 §3.2.2–3.2.3; Reverse labels and test adaptations are designed by CHAMGAP
N26 · Original axes, Korean/English text, dates and corrections
Required materials and conditions
Distinction between original subclaim and parent values, original reference date and correction/history
Conditions for verification
Corresponding original materials and analysis scope for Distinction between original subclaim and parent values, original reference date and correction/history must be supplied so unverified matters can be distinguished. Preserved wording is linked here; existing content review remains incomplete.
Requirement and applicability
Required
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Why this condition is needed
Preparation item distinguishing Distinction between original subclaim and parent values, original reference date and correction/history to link required and current materials for the selected question.
Referenced methods
M04 §4.5, §4.6.3; limits of this material conversion follow the review scope and internal design; M03 §3.1, §3.2.1–3.2.4 question-clarification principles; detailed separation rules are internally designed
N27 · Actual summary reading and unread external materials
Required materials and conditions
Actual reading by material, bibliography/URLs and additional-material gaps
Conditions for verification
Actual reading by material, bibliography/URLs and additional-material gaps: relevant original material and analysis scope must be provided with unverified matters distinguished. This conversion links preserved wording; existing content review remains incomplete.
Requirement and applicability
Required
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Why this condition is needed
A production item distinguishing Actual reading by material, bibliography/URLs and additional-material gaps to connect the selected question’s needed material with current material.
Referenced methods
M04 §4.5–4.6 material collection/selection principles; acquisition/reading separation and hyperlink specifications are internally designed; M04 §4.5, §4.6.3; limits of this material conversion follow the review scope and internal design
Referenced methods and the sections actually reviewed

M03 · Cochrane Handbook 6.5 (2024), chapter updated 2023-08

Official methodology · §3.1, §3.2.1–3.2.3, MECIR C5/C7/C13

Referenced principle
Clearly record the question, eligibility conditions and reasons for changes, and distinguish variations in interventions.
Extent of review
Preserved method HTML copies; no current method-content re-review or official tool execution

M04 · Cochrane Handbook 6.5.1 (2025), chapter updated 2025-03

Official methodology · §4.5, §4.6.1–4.6.3, MECIR C42

Referenced principle
Distinguish studies from reports and link them; do not omit a study solely because results are unreported.
Extent of review
Preserved method HTML copies; no current method-content re-review or official tool execution

M08 · Cochrane Handbook 6.5 (2024), chapter updated 2019-10

Official methodology · §8.1–8.2.3, Table 8.2.a

Referenced principle
Define the outcome and effect of interest, then examine randomization, deviations, missing data, measurement and selective reporting.
Extent of review
Preserved method HTML copies; no current method-content re-review or official tool execution

M15 · Cochrane Handbook 6.5 (2024), chapter updated 2023-08

Official methodology · §15.2.4, §15.3.1–15.3.3

Referenced principle
Distinguish effect estimates, intervals, importance and applicability. Sample size alone does not determine precision.
Extent of review
Preserved method HTML copies; no current method-content re-review or official tool execution

M19 · Cochrane Handbook 6.5 (2024), chapter updated 2019-10

Official methodology · §19.1.2, §19.2.1–19.2.4

Referenced principle
Harm questions may require different designs, populations and follow-up from efficacy questions. Case reports do not establish incidence rates.
Extent of review
Preserved method HTML copies; no current method-content re-review or official tool execution
What the statuses mean
Met
Status for necessary evidence confirmed after existing content review. No completion is declared in the current presentation.
Partly verified
Some information in the stored summary is linked into the table. External comparison/content review is not complete.
Unverified
The article leaves this unverified, or required material is absent from the current stored summary. This is distinct from zero, absence or safety.
Review incomplete
Existing content review remains incomplete.
Not reported
Not reported within the stored material actually read; not extended to the entire primary paper.
Inaccessible
Means an actual access failure. Access not attempted here is not assigned this state.
Not applicable
Not used as a substitute for an evidence gap.
Conflicting data
Requires an observed disagreement under the same comparison criteria; not automatically judged in this production.
Insufficient evidence for the conditions
Marks a gap in additional material required by the selected conditions; not a new efficacy grade.

Change history

2026-10-12 · Public page/material version 1.0

Public pages and materials were prepared from the existing 27 items. No new clinical search, verification-status change or scoring was performed.

The stored-material review date (Not recorded) and original evidence cut-off (2026-08-26) were retained unchanged.

Researcher downloads

These materials provide the same evidence, scope and verification status as this page.

View all item details

N01 · Selected FPG question and original values

Current findings
The original FPG-only incidence-reduction subclaim is C. Parent D34 is context for the original prespecified composite-incidence verdict, not the subclaim score/axes.
Verification status
Partly verified
Materials actually read
Summary read; external material unread
Why unverified
Only the corresponding preserved-summary information is recorded; detailed originals remain unread and existing content review incomplete. Subclaim score, status and axes are absent; parent values are not inserted. Existing content review remains incomplete.
Reason for missing information
Subclaim score, status and axes are absent; parent values are not inserted.
Required materials and conditions
Selected subclaim grade/note, parent context and presence of score/status/axes
Materials to obtain first
Materials distinguishing the selected record from the parent original verdict
Further research
Proposal to link the original question scope to additional materials for updating; no new investigation, calculation or trial was performed.
Remaining uncertainty
This record links preserved-summary statements; it does not establish external-paper comparison, a new efficacy verdict or completed content review.
Conditions for verification
Corresponding original materials and analysis scope for Selected subclaim grade/note, parent context and presence of score/status/axes must be supplied so unverified matters can be distinguished. Preserved wording is linked here; existing content review remains incomplete.
Why this condition is needed
Preparation item distinguishing Selected subclaim grade/note, parent context and presence of score/status/axes to link required and current materials for the selected question.
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Referenced methods
M03 §3.1, §3.2.1–3.2.4 question-clarification principles; detailed separation rules are custom design; M03 §3.2.4, M15 §15.3.1–15.3.3; question-specific outcome adaptation is custom design; M04 §4.5, §4.6.3; limits on current material conversion reflect the review scope and custom design

Related sources S01 S02

N02 · High-risk adults without diabetes in Kerala

Current findings
The original population comprises 1,007 community residents aged 30-60 in Kerala, India, with IDRS at least 60 and no diabetes.
Verification status
Partly verified
Materials actually read
Summary read; external material unread
Why unverified
Only the corresponding preserved-summary information is recorded; detailed originals remain unread and existing content review incomplete. Baseline FPG/HbA1c, detailed eligibility/risk, group characteristics and the selected FPG denominator are unverified. Existing content review remains incomplete.
Reason for missing information
Baseline FPG/HbA1c, detailed eligibility/risk, group characteristics and the selected FPG denominator are unverified.
Required materials and conditions
Population, recruitment criteria, baseline state and applicability
Materials to obtain first
Recruitment, eligibility, baseline characteristics and outcome-specific population materials
Further research
Proposal to examine applicability under the same population specification; no new investigation, calculation or trial was performed.
Remaining uncertainty
This record links preserved-summary statements; it does not establish external-paper comparison, a new efficacy verdict or completed content review.
Conditions for verification
Corresponding original materials and analysis scope for Population, recruitment criteria, baseline state and applicability must be supplied so unverified matters can be distinguished. Preserved wording is linked here; existing content review remains incomplete.
Why this condition is needed
Preparation item distinguishing Population, recruitment criteria, baseline state and applicability to link required and current materials for the selected question.
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Referenced methods
M03 §3.2.1; detailed population conditions are custom design; M03 §3.2.1–3.2.4; dose/duration/effect-modification details are custom design; M08 Table 8.2.a, M15 §15.3, M19 §19.1.2–19.2.4; design-specific adaptation is custom design

Related sources S01 S02

N03 · Trained peers and monthly group program

Current findings
The original intervention is a 12-month monthly group lifestyle program led by trained community peers. It is not replaced with a single activity or intensive expert-led intervention.
Verification status
Partly verified
Materials actually read
Summary read; external material unread
Why unverified
Only the corresponding preserved-summary information is recorded; detailed originals remain unread and existing content review incomplete. Education/session components, attendance, facilitator training, fidelity and actual individual exposure are unverified. Existing content review remains incomplete.
Reason for missing information
Education/session components, attendance, facilitator training, fidelity and actual individual exposure are unverified.
Required materials and conditions
Intervention components, facilitators, intensity and actual delivery
Materials to obtain first
Original program components, attendance/fidelity and exposure materials
Further research
Proposal to examine program components and actual delivery; no new investigation, calculation or trial was performed.
Remaining uncertainty
This record links preserved-summary statements; it does not establish external-paper comparison, a new efficacy verdict or completed content review.
Conditions for verification
Corresponding original materials and analysis scope for Intervention components, facilitators, intensity and actual delivery must be supplied so unverified matters can be distinguished. Preserved wording is linked here; existing content review remains incomplete.
Why this condition is needed
Preparation item distinguishing Intervention components, facilitators, intensity and actual delivery to link required and current materials for the selected question.
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Referenced methods
M03 §3.2.2–3.2.3; reverse-direction labels and checking adaptations are internally designed; M03 §3.2.3, M08 §8.2.2–8.2.3; internal application; M03 §3.2.1–3.2.4; dose, duration and effect-modification details are internally designed

Related sources S01 S02

N04 · Education-booklet control

Current findings
Original allocation of 500 intervention participants and 507 education-booklet participants is retained. The control is not described as no action, no information or identical conditions.
Verification status
Partly verified
Materials actually read
Summary read; external material unread
Why unverified
Only the corresponding preserved-summary information is recorded; detailed originals remain unread and existing content review incomplete. Booklet content/use, other support/exposure and actual control participation are unverified. Existing content review remains incomplete.
Reason for missing information
Booklet content/use, other support/exposure and actual control participation are unverified.
Required materials and conditions
Actual control and differences in accompanying exposure
Materials to obtain first
Control components, use and accompanying exposure materials
Further research
Proposal to distinguish the actual intervention/control differences; no new investigation, calculation or trial was performed.
Remaining uncertainty
This record links preserved-summary statements; it does not establish external-paper comparison, a new efficacy verdict or completed content review.
Conditions for verification
Corresponding original materials and analysis scope for Actual control and differences in accompanying exposure must be supplied so unverified matters can be distinguished. Preserved wording is linked here; existing content review remains incomplete.
Why this condition is needed
Preparation item distinguishing Actual control and differences in accompanying exposure to link required and current materials for the selected question.
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Referenced methods
M03 §3.2.2–3.2.3; Reverse labels and test adaptations are designed by CHAMGAP; M03 §3.2.3, M08 §8.2.2–8.2.3; CHAMGAP adaptation; M04 §4.6.3, M15 §15.3.1–15.3.3; Status distinctions are designed by CHAMGAP

Related sources S01 S02

N05 · 12-month intervention and nine-year follow-up

Current findings
The monthly program lasted 12 months; nine-year outcomes are long-term follow-up of the same trial. Continued identical intervention throughout nine years is not assumed.
Verification status
Partly verified
Materials actually read
Summary read; external material unread
Why unverified
Only the corresponding preserved-summary information is recorded; detailed originals remain unread and existing content review incomplete. Individual attendance/exposure, subsequent activity/treatment, assessment windows and discontinuation/crossover are unverified. Existing content review remains incomplete.
Reason for missing information
Individual attendance/exposure, subsequent activity/treatment, assessment windows and discontinuation/crossover are unverified.
Required materials and conditions
Distinction between exposure duration and outcome follow-up
Materials to obtain first
Intervention/follow-up timing, actual exposure and change records
Further research
Proposal to examine exposure and long-term outcomes; no new investigation, calculation or trial was performed.
Remaining uncertainty
This record links preserved-summary statements; it does not establish external-paper comparison, a new efficacy verdict or completed content review.
Conditions for verification
Corresponding original materials and analysis scope for Distinction between exposure duration and outcome follow-up must be supplied so unverified matters can be distinguished. Preserved wording is linked here; existing content review remains incomplete.
Why this condition is needed
Preparation item distinguishing Distinction between exposure duration and outcome follow-up to link required and current materials for the selected question.
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Referenced methods
M03 §3.2.4 and M15 §§15.3.1–15.3.3; question-specific outcome adaptation is Chamgap-designed; M03 §3.2.3 and M08 §§8.2.2–8.2.3; Chamgap adaptation; M03 §§3.2.1–3.2.4; dose, durability and effect-modification details are Chamgap-designed

Related sources S01 S02

N06 · Cluster allocation of 60 polling areas

Current findings
The original design cluster randomized 60 polling areas. Clusters, intervention/control groups and individuals are not counted as independent trials.
Verification status
Partly verified
Materials actually read
Summary read; external material unread
Why unverified
Only the corresponding preserved-summary information is recorded; detailed originals remain unread and existing content review incomplete. Allocation generation/concealment, stratification, cluster sizes, access rights and actual procedures are unread. Existing content review remains incomplete.
Reason for missing information
Allocation generation/concealment, stratification, cluster sizes, access rights and actual procedures are unread.
Required materials and conditions
Cluster/individual units and allocation/concealment procedures
Materials to obtain first
Cluster allocation, cluster-specific populations and procedure materials
Further research
Proposal to examine cluster structure and population distribution; no new investigation, calculation or trial was performed.
Remaining uncertainty
This record links preserved-summary statements; it does not establish external-paper comparison, a new efficacy verdict or completed content review.
Conditions for verification
Corresponding original materials and analysis scope for Cluster/individual units and allocation/concealment procedures must be supplied so unverified matters can be distinguished. Preserved wording is linked here; existing content review remains incomplete.
Why this condition is needed
Preparation item distinguishing Cluster/individual units and allocation/concealment procedures to link required and current materials for the selected question.
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Referenced methods
M08 §8.1–8.2.3; CHAMGAP adaptation; Distinction between studies and reports in M04 §4.6.1–4.6.2; Cohort/outcome connections are CHAMGAP adaptations; M08 Table 8.2.a, M15 §15.3, M19 §19.1.2–19.2.4; Design-specific adaptations are designed by CHAMGAP; Material collection/selection principles in M04 §4.5–4.6; Separating access from reading and defining hyperlink behavior are designed by CHAMGAP

Related sources S01 S02

N07 · Masking and measurement roles

Current findings
The stored cluster-intervention design is linked to test-based outcomes.
Verification status
Unverified
Materials actually read
Summary read; external material unread
Why unverified
Currently required information is unverified in the preserved summary. Actual masking, test access and roles of participants/facilitators, laboratory staff/adjudicators and analysts are unverified. The design name alone does not certify absence of bias. Existing content review remains incomplete.
Reason for missing information
Actual masking, test access and roles of participants/facilitators, laboratory staff/adjudicators and analysts are unverified. The design name alone does not certify absence of bias.
Required materials and conditions
Role-specific procedures for incidence adjudication, testing and analysis
Materials to obtain first
Testing/adjudication/analysis procedures and role-specific masking materials
Further research
Proposal to examine measurement/adjudication bias; no new investigation, calculation or trial was performed.
Remaining uncertainty
This record links preserved-summary statements; it does not establish external-paper comparison, a new efficacy verdict or completed content review.
Conditions for verification
Corresponding original materials and analysis scope for Role-specific procedures for incidence adjudication, testing and analysis must be supplied so unverified matters can be distinguished. Preserved wording is linked here; existing content review remains incomplete.
Why this condition is needed
Preparation item distinguishing Role-specific procedures for incidence adjudication, testing and analysis to link required and current materials for the selected question.
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Referenced methods
M08 Table 8.2.a, M03 §3.2.4; CHAMGAP adaptation; Material collection/selection principles in M04 §4.5–4.6; Separating access from reading and defining hyperlink behavior are designed by CHAMGAP

Related sources S01 S02

N08 · FPG-only definition and testing

Current findings
The original account of a positive result using FPG alone is retained. All components/procedures of the prespecified composite definition are not automatically applied to this definition.
Verification status
Partly verified
Materials actually read
Summary read; external material unread
Why unverified
Only the corresponding preserved-summary information is recorded; detailed originals remain unread and existing content review incomplete. The selected FPG cutoff, fasting/testing, repeat confirmation, inclusion of physician diagnosis/medication and detailed event unit are unverified. Existing content review remains incomplete.
Reason for missing information
The selected FPG cutoff, fasting/testing, repeat confirmation, inclusion of physician diagnosis/medication and detailed event unit are unverified.
Required materials and conditions
Selected incidence cutoff, testing/confirmation and event unit
Materials to obtain first
Original FPG-only definition, testing/confirmation and adjudication materials
Further research
Proposal to examine results under the definition/measurement specification; no new investigation, calculation or trial was performed.
Remaining uncertainty
This record links preserved-summary statements; it does not establish external-paper comparison, a new efficacy verdict or completed content review.
Conditions for verification
Corresponding original materials and analysis scope for Selected incidence cutoff, testing/confirmation and event unit must be supplied so unverified matters can be distinguished. Preserved wording is linked here; existing content review remains incomplete.
Why this condition is needed
Preparation item distinguishing Selected incidence cutoff, testing/confirmation and event unit to link required and current materials for the selected question.
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Referenced methods
M03 §3.2.4, M15 §15.3.1–15.3.3; outcome adaptation to each question is internally designed; M08 Table 8.2.a, M03 §3.2.4; internal application; M08 Table 8.2.a, M04 §4.6.3; internal application

Related sources S01

N09 · FPG RR0.72·CI·P

Current findings
Original FPG-only RR 0.72 (95% CI 0.53-0.98), P=.036 is retained. No new risk difference, NNT or effect/CI is calculated.
Verification status
Partly verified
Materials actually read
Summary read; external material unread
Why unverified
Only the corresponding preserved-summary information is recorded; detailed originals remain unread and existing content review incomplete. Group-specific events/denominators, cluster adjustment, adjustment variables, estimation model and original output are unverified. Existing content review remains incomplete.
Reason for missing information
Group-specific events/denominators, cluster adjustment, adjustment variables, estimation model and original output are unverified.
Required materials and conditions
Selected between-group estimate, confidence interval and model
Materials to obtain first
Group-specific results, model and exact output for the selected definition
Further research
Proposal to examine precision for the same definition/estimate; no new investigation, calculation or trial was performed.
Remaining uncertainty
This record links preserved-summary statements; it does not establish external-paper comparison, a new efficacy verdict or completed content review.
Conditions for verification
Corresponding original materials and analysis scope for Selected between-group estimate, confidence interval and model must be supplied so unverified matters can be distinguished. Preserved wording is linked here; existing content review remains incomplete.
Why this condition is needed
Preparation item distinguishing Selected between-group estimate, confidence interval and model to link required and current materials for the selected question.
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Referenced methods
M15 §15.3.1–15.3.3; CHAMGAP adaptation; M08 §8.2.2, M15 §15.3.1; CHAMGAP adaptation; M08 Table 8.2.a, M15 §15.3, M19 §19.1.2–19.2.4; Design-specific adaptations are designed by CHAMGAP

Related sources S01

N10 · FPG events, denominators and timing

Current findings
The FPG-only result is linked to the nine-year discussion context. Composite-incidence 125/419 and 142/422 are not transferred to FPG events/denominators.
Verification status
Partly verified
Materials actually read
Summary read; external material unread
Why unverified
Only the corresponding preserved-summary information is recorded; detailed originals remain unread and existing content review incomplete. FPG group-specific event counts, denominators, assessment windows, cumulative/repeated events and omission/missingness handling are unverified. Existing content review remains incomplete.
Reason for missing information
FPG group-specific event counts, denominators, assessment windows, cumulative/repeated events and omission/missingness handling are unverified.
Required materials and conditions
Selected-definition analysis/observed denominator, events and time
Materials to obtain first
Definition-specific observed/analysis populations, events and timing materials
Further research
Proposal to examine the same people and definition-specific outcomes; no new investigation, calculation or trial was performed.
Remaining uncertainty
This record links preserved-summary statements; it does not establish external-paper comparison, a new efficacy verdict or completed content review.
Conditions for verification
Corresponding original materials and analysis scope for Selected-definition analysis/observed denominator, events and time must be supplied so unverified matters can be distinguished. Preserved wording is linked here; existing content review remains incomplete.
Why this condition is needed
Preparation item distinguishing Selected-definition analysis/observed denominator, events and time to link required and current materials for the selected question.
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Referenced methods
M08 Table 8.2.a, M15 §15.3, M19 §19.1.2–19.2.4; Design-specific adaptations are designed by CHAMGAP; M03 §3.2.4, M15 §15.3.1–15.3.3; Question-specific outcome adaptations are designed by CHAMGAP; M08 §8.2.2, M15 §15.3.1; CHAMGAP adaptation; Distinction between studies and reports in M04 §4.6.1–4.6.2; Cohort/outcome connections are CHAMGAP adaptations

Related sources S01

N11 · Prespecified composite-incidence definition

Current findings
The original prespecified primary definition is cumulative incidence based on FPG at least 126 mg/dL or HbA1c at least 6.5%, including physician diagnosis or initiation of glucose-lowering medication during follow-up. It is not replaced by FPG-only results.
Verification status
Partly verified
Materials actually read
Summary read; external material unread
Why unverified
Only the corresponding preserved-summary information is recorded; detailed originals remain unread and existing content review incomplete. Original component-specific events, overlap/confirmation procedures and planning/change history are unread. Existing content review remains incomplete.
Reason for missing information
Original component-specific events, overlap/confirmation procedures and planning/change history are unread.
Required materials and conditions
Components/hierarchy of the prespecified primary definition and its relation to the selected definition
Materials to obtain first
Prespecified definition, component-specific adjudication and original plans
Further research
Proposal to distinguish definition/hierarchy and component-specific outcomes; no new investigation, calculation or trial was performed.
Remaining uncertainty
This record links preserved-summary statements; it does not establish external-paper comparison, a new efficacy verdict or completed content review.
Conditions for verification
Corresponding original materials and analysis scope for Components/hierarchy of the prespecified primary definition and its relation to the selected definition must be supplied so unverified matters can be distinguished. Preserved wording is linked here; existing content review remains incomplete.
Why this condition is needed
Preparation item distinguishing Components/hierarchy of the prespecified primary definition and its relation to the selected definition to link required and current materials for the selected question.
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Referenced methods
M08 Table 8.2.a, M04 §4.6.3; CHAMGAP adaptation; M03 §3.2.4, M15 §15.3.1–15.3.3; Question-specific outcome adaptations are designed by CHAMGAP; M08 Table 8.2.a, M03 §3.2.4; CHAMGAP adaptation; M04 §4.6.3, M15 §15.3.1–15.3.3; Status distinctions are designed by CHAMGAP

Related sources S01

N12 · Original nine-year composite result

Current findings
Prespecified nine-year composite 125/419 (30%) versus 142/422 (34%), RR 0.88 (0.73-1.08), P=.24 is retained as context. These are not the selected FPG events/estimate.
Verification status
Partly verified
Materials actually read
Summary read; external material unread
Why unverified
Only the corresponding preserved-summary information is recorded; detailed originals remain unread and existing content review incomplete. Correspondence of people/events across definitions and component-specific outcomes/denominators are unverified. No new difference, ratio or interaction is calculated. Existing content review remains incomplete.
Reason for missing information
Correspondence of people/events across definitions and component-specific outcomes/denominators are unverified. No new difference, ratio or interaction is calculated.
Required materials and conditions
Between-group outcomes under the other definition, distinguished from selected FPG
Materials to obtain first
Composite/FPG definition correspondence and original analysis materials
Further research
Proposal to distinguish definition-specific outcomes within the same cohort; no new investigation, calculation or trial was performed.
Remaining uncertainty
This record links preserved-summary statements; it does not establish external-paper comparison, a new efficacy verdict or completed content review.
Conditions for verification
Corresponding original materials and analysis scope for Between-group outcomes under the other definition, distinguished from selected FPG must be supplied so unverified matters can be distinguished. Preserved wording is linked here; existing content review remains incomplete.
Why this condition is needed
Preparation item distinguishing Between-group outcomes under the other definition, distinguished from selected FPG to link required and current materials for the selected question.
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Referenced methods
M04 §4.6.3, M15 §15.3.1–15.3.3; Status distinctions are designed by CHAMGAP; M03 §3.2.4, M15 §15.3.1–15.3.3; Question-specific outcome adaptations are designed by CHAMGAP; M15 §15.3.1–15.3.3; CHAMGAP adaptation; Distinction between studies and reports in M04 §4.6.1–4.6.2; Cohort/outcome connections are CHAMGAP adaptations

Related sources S01

N13 · Multiple definitions, selection and multiplicity

Current findings
The original note that the positive FPG-only result was not the prespecified primary endpoint is retained. Selecting only the positive definition does not create an overall conclusion or new grade.
Verification status
Partly verified
Materials actually read
Summary read; external material unread
Why unverified
Only the corresponding preserved-summary information is recorded; detailed originals remain unread and existing content review incomplete. Definition list, prespecified hierarchy, multiplicity/adjustment, testing strategy and SAP are unread. Existing content review remains incomplete.
Reason for missing information
Definition list, prespecified hierarchy, multiplicity/adjustment, testing strategy and SAP are unread.
Required materials and conditions
Prespecification of the selected positive result and multiplicity/overall-result specification
Materials to obtain first
Original plans, SAP and all definition/testing results
Further research
Proposal to examine selection/multiplicity and result interpretation; no new investigation, calculation or trial was performed.
Remaining uncertainty
This record links preserved-summary statements; it does not establish external-paper comparison, a new efficacy verdict or completed content review.
Conditions for verification
Corresponding original materials and analysis scope for Prespecification of the selected positive result and multiplicity/overall-result specification must be supplied so unverified matters can be distinguished. Preserved wording is linked here; existing content review remains incomplete.
Why this condition is needed
Preparation item distinguishing Prespecification of the selected positive result and multiplicity/overall-result specification to link required and current materials for the selected question.
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Referenced methods
M08 Table 8.2.a, M04 §4.6.3; CHAMGAP adaptation; M04 §4.6.3, M15 §15.3.1–15.3.3; Status distinctions are designed by CHAMGAP; M15 §15.3.1–15.3.3; CHAMGAP adaptation

Related sources S01

N14 · 1,007·500/507·841

Current findings
The 1,007 randomized participants (500/507) and 841 with nine-year outcome data (419/422) are retained separately. They are not described as full ITT or a verified identical denominator for selected FPG.
Verification status
Partly verified
Materials actually read
Summary read; external material unread
Why unverified
Only the corresponding preserved-summary information is recorded; detailed originals remain unread and existing content review incomplete. Group-specific inclusion/exclusion flow, FPG observation, death/withdrawal/missingness and cluster analysis are unverified. Existing content review remains incomplete.
Reason for missing information
Group-specific inclusion/exclusion flow, FPG observation, death/withdrawal/missingness and cluster analysis are unverified.
Required materials and conditions
Randomized population distinguished from the nine-year available-case analysis population
Materials to obtain first
Flow from randomization to definition-specific observation/analysis populations
Further research
A follow-up research proposal on analysis populations and omission assumptions; no new investigation, calculation or trial is performed in this conversion.
Remaining uncertainty
This record links preserved-summary statements; it does not establish external-paper comparison, a new efficacy verdict or completed content review.
Conditions for verification
Corresponding original materials and analysis scope for Randomized population distinguished from the nine-year available-case analysis population must be supplied so unverified matters can be distinguished. Preserved wording is linked here; existing content review remains incomplete.
Why this condition is needed
Preparation item distinguishing Randomized population distinguished from the nine-year available-case analysis population to link required and current materials for the selected question.
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Referenced methods
M08 Table 8.2.a, M15 §15.3, M19 §19.1.2–19.2.4; design-specific adaptation is custom design; M08 §8.2.2, M15 §15.3.1; custom application; M04 §4.6.1–4.6.2 distinction between studies and reports; cohort/outcome linkage is a custom application

Related sources S01

N15 · Loss to follow-up: 144 and 14.3%

Current findings
Original loss to follow-up of 144/1,007 (14.3%), below 15%, is retained. The separate 1,007 and 841 analysis accounts are not subtracted/reconciled to create new omission counts.
Verification status
Partly verified
Materials actually read
Summary read; external material unread
Why unverified
Only the corresponding preserved-summary information is recorded; detailed originals remain unread and existing content review incomplete. Stage-specific follow-up/analysis definitions, group-specific reasons, death/unmeasured exclusions and FPG missingness are unverified. Existing content review remains incomplete.
Reason for missing information
Stage-specific follow-up/analysis definitions, group-specific reasons, death/unmeasured exclusions and FPG missingness are unverified.
Required materials and conditions
Original loss-to-follow-up account and its relation to available cases
Materials to obtain first
Stage-specific follow-up, analysis exclusion/missingness flows and reasons
Further research
Proposal to distinguish loss to follow-up from the actual analyzable population; no new investigation, calculation or trial was performed.
Remaining uncertainty
This record links preserved-summary statements; it does not establish external-paper comparison, a new efficacy verdict or completed content review.
Conditions for verification
Corresponding original materials and analysis scope for Original loss-to-follow-up account and its relation to available cases must be supplied so unverified matters can be distinguished. Preserved wording is linked here; existing content review remains incomplete.
Why this condition is needed
Preparation item distinguishing Original loss-to-follow-up account and its relation to available cases to link required and current materials for the selected question.
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Referenced methods
M08 Table 8.2.a, M15 §15.3, M19 §19.1.2–19.2.4; Design-specific adaptations are designed by CHAMGAP; M08 §8.2.2, M15 §15.3.1; CHAMGAP adaptation; Material collection/selection principles in M04 §4.5–4.6; Separating access from reading and defining hyperlink behavior are designed by CHAMGAP

Related sources S01 S02

N16 · Cluster analysis, missingness and sensitivity

Current findings
The original nine-year available-case account and cluster-randomized structure are retained.
Verification status
Partly verified
Materials actually read
Summary read; external material unread
Why unverified
Only the corresponding preserved-summary information is recorded; detailed originals remain unread and existing content review incomplete. Selected FPG cluster correlation, adjustment, missingness models, sensitivity and estimates for all randomized participants are unverified. No new model/effect is calculated. Existing content review remains incomplete.
Reason for missing information
Selected FPG cluster correlation, adjustment, missingness models, sensitivity and estimates for all randomized participants are unverified. No new model/effect is calculated.
Required materials and conditions
Analysis specification for cluster adjustment, available cases and missingness assumptions
Materials to obtain first
Original FPG analysis, cluster/missingness handling and sensitivity materials
Further research
Proposal to examine uncertainty under cluster/missingness assumptions; no new investigation, calculation or trial was performed.
Remaining uncertainty
This record links preserved-summary statements; it does not establish external-paper comparison, a new efficacy verdict or completed content review.
Conditions for verification
Corresponding original materials and analysis scope for Analysis specification for cluster adjustment, available cases and missingness assumptions must be supplied so unverified matters can be distinguished. Preserved wording is linked here; existing content review remains incomplete.
Why this condition is needed
Preparation item distinguishing Analysis specification for cluster adjustment, available cases and missingness assumptions to link required and current materials for the selected question.
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Referenced methods
M08 §8.2.2, M15 §15.3.1; custom application; M08 Table 8.2.a, M15 §15.3, M19 §19.1.2–19.2.4; design-specific adaptation is custom design; M15 §15.3.1–15.3.3; custom application

Related sources S01

N17 · Earlier 24-month report of the same trial

Current findings
S02 is the same K-DPP trial’s earlier 24-month report. Its primary result is retained as 68/456 (14.9%) versus 79/463 (17.1%), RR 0.88 (0.66-1.16), P=.36. It does not become the nine-year FPG-only result or a separate independent trial.
Verification status
Partly verified
Materials actually read
Summary read; external material unread
Why unverified
Only the corresponding preserved-summary information is recorded; detailed originals remain unread and existing content review incomplete. Original 24-month definition, clusters/denominators, attrition/missingness, population correspondence to nine years and FPG-specific values are unverified. Existing content review remains incomplete.
Reason for missing information
Original 24-month definition, clusters/denominators, attrition/missingness, population correspondence to nine years and FPG-specific values are unverified.
Required materials and conditions
Population, timing and results of the earlier report and relation to nine years
Materials to obtain first
Original 24-month report, definition/population/denominators and long-term correspondence
Further research
Follow-up proposal to distinguish time/definition-specific outcomes in the same cohort; no new investigation, calculation or trial was performed.
Remaining uncertainty
This record links preserved-summary statements; it does not establish external-paper comparison, a new efficacy verdict or completed content review.
Conditions for verification
Corresponding original materials and analysis scope for Population, timing and results of the earlier report and relation to nine years must be supplied so unverified matters can be distinguished. Preserved wording is linked here; existing content review remains incomplete.
Why this condition is needed
Preparation item distinguishing Population, timing and results of the earlier report and relation to nine years to link required and current materials for the selected question.
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Referenced methods
Distinction between studies and reports in M04 §4.6.1–4.6.2; Cohort/outcome connections are CHAMGAP adaptations; M03 §3.2.4, M15 §15.3.1–15.3.3; Question-specific outcome adaptations are designed by CHAMGAP; M04 §4.6.3, M15 §15.3.1–15.3.3; Status distinctions are designed by CHAMGAP; M08 §8.2.2, M15 §15.3.1; CHAMGAP adaptation

Related sources S02

N18 · Paired registration identifiers

Current findings
Original ACTRN12611000262909 · CTRI/2021/10/037191 in the registration field is retained. The two identifiers are not counted as separate independent trials.
Verification status
Partly verified
Materials actually read
Summary read; external material unread
Why unverified
Only the corresponding preserved-summary information is recorded; detailed originals remain unread and existing content review incomplete. Each registration’s population/duration, prespecified plans, change history and relation to recruitment/analysis are unread. Existing content review remains incomplete.
Reason for missing information
Each registration’s population/duration, prespecified plans, change history and relation to recruitment/analysis are unread.
Required materials and conditions
Registration identity, scope of each identifier and original plans
Materials to obtain first
Each registration history, protocol/SAP and report correspondence
Further research
Proposal to link prespecified plans and report/registration relationships; no new investigation, calculation or trial was performed.
Remaining uncertainty
This record links preserved-summary statements; it does not establish external-paper comparison, a new efficacy verdict or completed content review.
Conditions for verification
Corresponding original materials and analysis scope for Registration identity, scope of each identifier and original plans must be supplied so unverified matters can be distinguished. Preserved wording is linked here; existing content review remains incomplete.
Why this condition is needed
Preparation item distinguishing Registration identity, scope of each identifier and original plans to link required and current materials for the selected question.
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Referenced methods
M08 Table 8.2.a, M04 §4.6.3; CHAMGAP adaptation; Material collection/selection principles in M04 §4.5–4.6; Separating access from reading and defining hyperlink behavior are designed by CHAMGAP; Distinction between studies and reports in M04 §4.6.1–4.6.2; Cohort/outcome connections are CHAMGAP adaptations

Related sources S01 S02

N19 · Concurrent activity, treatment and contamination

Current findings
The monthly group-intervention/education-booklet difference is retained within its original scope.
Verification status
Unverified
Materials actually read
Summary read; external material unread
Why unverified
Currently required information is unverified in the preserved summary. Group-specific diet/activity, expert support, testing/medication, external programs, contamination/crossover, actual adherence and subsequent exposure are unverified. No new lifestyle/treatment instructions are created. Existing content review remains incomplete.
Reason for missing information
Group-specific diet/activity, expert support, testing/medication, external programs, contamination/crossover, actual adherence and subsequent exposure are unverified. No new lifestyle/treatment instructions are created.
Required materials and conditions
Group-specific concurrent exposure, treatment/changes and actual participation
Materials to obtain first
Group-specific concurrent exposure, participation/adherence, changes and crossover records
Further research
Proposal to examine concurrent exposure and attribution of program outcomes; no new investigation, calculation or trial was performed.
Remaining uncertainty
This record links preserved-summary statements; it does not establish external-paper comparison, a new efficacy verdict or completed content review.
Conditions for verification
Corresponding original materials and analysis scope for Group-specific concurrent exposure, treatment/changes and actual participation must be supplied so unverified matters can be distinguished. Preserved wording is linked here; existing content review remains incomplete.
Why this condition is needed
Preparation item distinguishing Group-specific concurrent exposure, treatment/changes and actual participation to link required and current materials for the selected question.
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Referenced methods
M03 §3.2.3, M08 §8.2.2–8.2.3; custom application; M03 §3.2.2–3.2.3; reverse-direction labeling and test adaptation are custom design; M03 §3.2.1–3.2.4; dose/duration/effect-modification details are custom design

Related sources S01 S02

N20 · NHMRC funding and roles

Current findings
The original account of support from the Australian National Health and Medical Research Council is retained.
Verification status
Partly verified
Materials actually read
Summary read; external material unread
Why unverified
Only the corresponding preserved-summary information is recorded; detailed originals remain unread and existing content review incomplete. Contracts, involvement in analysis/writing/publication, individual author relationships/COI and time-specific disclosures are unread. Public funding alone does not certify complete independence. Existing content review remains incomplete.
Reason for missing information
Contracts, involvement in analysis/writing/publication, individual author relationships/COI and time-specific disclosures are unread. Public funding alone does not certify complete independence.
Required materials and conditions
Funding provision distinguished from research/analysis/publication roles
Materials to obtain first
Original funding/role, author-contribution/COI and publication-related disclosures
Further research
Proposal to distinguish support roles and reporting relationships; no new investigation, calculation or trial was performed.
Remaining uncertainty
This record links preserved-summary statements; it does not establish external-paper comparison, a new efficacy verdict or completed content review.
Conditions for verification
Corresponding original materials and analysis scope for Funding provision distinguished from research/analysis/publication roles must be supplied so unverified matters can be distinguished. Preserved wording is linked here; existing content review remains incomplete.
Why this condition is needed
Preparation item distinguishing Funding provision distinguished from research/analysis/publication roles to link required and current materials for the selected question.
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Referenced methods
Chamgap independence/attribution conditions. The referenced official method sections do not certify every detail of these items; Data collection/selection principles in M04 §4.5–4.6; Access/reading separation and hyperlink rules are Chamgap design

Related sources S01 S02

N21 · No commercial product and other support

Current findings
The original account that no commercial product was used is retained.
Verification status
Partly verified
Materials actually read
Summary read; external material unread
Why unverified
Only the corresponding preserved-summary information is recorded; detailed originals remain unread and existing content review incomplete. Product nonuse does not verify absence of all material/analysis/writing/publication-fee support, employee authors or COI. Individual disclosures are unread. Existing content review remains incomplete.
Reason for missing information
Product nonuse does not verify absence of all material/analysis/writing/publication-fee support, employee authors or COI. Individual disclosures are unread.
Required materials and conditions
Commercial-product use distinguished from other support/relationships
Materials to obtain first
Individual support, author relationships and disclosure materials
Further research
Proposal to distinguish product/other support; no new investigation, calculation or trial was performed.
Remaining uncertainty
This record links preserved-summary statements; it does not establish external-paper comparison, a new efficacy verdict or completed content review.
Conditions for verification
Corresponding original materials and analysis scope for Commercial-product use distinguished from other support/relationships must be supplied so unverified matters can be distinguished. Preserved wording is linked here; existing content review remains incomplete.
Why this condition is needed
Preparation item distinguishing Commercial-product use distinguished from other support/relationships to link required and current materials for the selected question.
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Referenced methods
Chamgap independence/attribution conditions. The referenced official method sections do not certify every detail of these items; Data collection/selection principles in M04 §4.5–4.6; Access/reading separation and hyperlink rules are Chamgap design

Related sources S01 S02

N22 · Nine-year and 24-month safety-reporting scope

Current findings
The original account is retained: no separate safety-outcome counts in the nine-year abstract, and no intervention-related adverse events reported at 24 months.
Verification status
Partly verified
Materials actually read
Summary read; external material unread
Why unverified
Only the corresponding preserved-summary information is recorded; detailed originals remain unread and existing content review incomplete. Actual harms collection, population/denominators, events, discontinuation and detailed nine-year originals are unread. Nonreporting/no related events does not establish zero long-term harms or certify safety. Existing content review remains incomplete.
Reason for missing information
Actual harms collection, population/denominators, events, discontinuation and detailed nine-year originals are unread. Nonreporting/no related events does not establish zero long-term harms or certify safety.
Required materials and conditions
Time-specific distinction between harms collection, reporting and denominators
Materials to obtain first
Time-specific harms collection, denominators and event/discontinuation materials
Further research
Proposal to examine long-term follow-up and harms-reporting gaps; no new investigation, calculation or trial was performed.
Remaining uncertainty
This record links preserved-summary statements; it does not establish external-paper comparison, a new efficacy verdict or completed content review.
Conditions for verification
Corresponding original materials and analysis scope for Time-specific distinction between harms collection, reporting and denominators must be supplied so unverified matters can be distinguished. Preserved wording is linked here; existing content review remains incomplete.
Why this condition is needed
Preparation item distinguishing Time-specific distinction between harms collection, reporting and denominators to link required and current materials for the selected question.
Application exceptions
Supplements the selected subclaim’s safety-material gap. Incidence results or parent safety wording do not establish safety or generate harm rates or new usage instructions.
Referenced methods
M19 §19.1.2–19.2.4; detailed distinctions are Chamgap’s own design; M19 §19.1.2–19.2.4; Chamgap application; M19 §19.1.2–19.2.4; Chamgap application; M19 §19.1.2–19.2.4; Chamgap application

Related sources S01 S02

N23 · Intensive expert programs and other evidence

Current findings
Only the original context mentioning DPP/DPS and intensive expert-led intervention in 1531 is retained. These are not transferred as the same direct report for the monthly peer-led intervention/selected FPG.
Verification status
Partly verified
Materials actually read
Summary read; external material unread
Why unverified
Only the corresponding preserved-summary information is recorded; detailed originals remain unread and existing content review incomplete. Individual population, intervention, bibliography, estimates and direct correspondence for those trials are not linked in this source and remain unverified. Existing content review remains incomplete.
Reason for missing information
Individual population, intervention, bibliography, estimates and direct correspondence for those trials are not linked in this source and remain unverified.
Required materials and conditions
Intervention intensity/components and other trials’ identities/results
Materials to obtain first
Materials for each trial/intervention/population mentioned in the original account
Further research
Proposal to distinguish intervention intensity/components and result applicability; no new investigation, calculation or trial was performed.
Remaining uncertainty
This record links preserved-summary statements; it does not establish external-paper comparison, a new efficacy verdict or completed content review.
Conditions for verification
Corresponding original materials and analysis scope for Intervention intensity/components and other trials’ identities/results must be supplied so unverified matters can be distinguished. Preserved wording is linked here; existing content review remains incomplete.
Why this condition is needed
Preparation item distinguishing Intervention intensity/components and other trials’ identities/results to link required and current materials for the selected question.
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Referenced methods
M04 §4.6.3, M15 §15.3.1–15.3.3; Status distinctions are designed by CHAMGAP; M03 §3.2.2–3.2.3; Reverse labels and test adaptations are designed by CHAMGAP; M03 §3.2.1–3.2.4; Dose, duration and effect-modification details are designed by CHAMGAP; Distinction between studies and reports in M04 §4.6.1–4.6.2; Cohort/outcome connections are CHAMGAP adaptations

Related sources S01 S02

N24 · Independence, follow-up reports and sibling sheets

Current findings
Jeemon’s 2026 nine-year report and Thankappan’s 2018 24-month report are linked as reports of the same trial. Shared 60 clusters, people/groups, definitions, time points and sibling sheets are not added as new independent trials/participants.
Verification status
Partly verified
Materials actually read
Summary read; external material unread
Why unverified
Only the corresponding preserved-summary information is recorded; detailed originals remain unread and existing content review incomplete. Actual people/cluster/time correspondence, unique participants and independent replication have not been checked against external materials. Original R1 is not inherited as new independence certification. Existing content review remains incomplete.
Reason for missing information
Actual people/cluster/time correspondence, unique participants and independent replication have not been checked against external materials. Original R1 is not inherited as new independence certification.
Required materials and conditions
Relationships among reports, trials, people, time points and definitions
Materials to obtain first
Report/registration/population, time/definition relationships and separate replication materials
Further research
Proposal to distinguish the same trial from separate evidence; no new investigation, calculation or trial was performed.
Remaining uncertainty
This record links preserved-summary statements; it does not establish external-paper comparison, a new efficacy verdict or completed content review.
Conditions for verification
Corresponding original materials and analysis scope for Relationships among reports, trials, people, time points and definitions must be supplied so unverified matters can be distinguished. Preserved wording is linked here; existing content review remains incomplete.
Why this condition is needed
Preparation item distinguishing Relationships among reports, trials, people, time points and definitions to link required and current materials for the selected question.
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Referenced methods
M04 §4.6.1–4.6.2 distinction between studies and reports; cohort/outcome linkage is a custom application; M04 §4.6.1–4.6.2, M15 §15.3.1; custom application; M04 §4.5, §4.6.3; limits on current material conversion reflect the review scope and custom design

Related sources S01 S02

N25 · Nine years and other durations/populations

Current findings
The selected positive result concerns the FPG-only definition for a low-cost peer-led program. It is not extended to preventive efficacy or ineffectiveness across all definitions, intensive expert-led interventions or other populations.
Verification status
Partly verified
Materials actually read
Summary read; external material unread
Why unverified
Only the corresponding preserved-summary information is recorded; detailed originals remain unread and existing content review incomplete. Other recruitment criteria, eras, intensity/duration, long-term clinical outcomes/harms and definition-specific correspondence are unverified. Existing content review remains incomplete.
Reason for missing information
Other recruitment criteria, eras, intensity/duration, long-term clinical outcomes/harms and definition-specific correspondence are unverified.
Required materials and conditions
Other populations, durations/intensity and long-term follow-up beyond this question
Materials to obtain first
Additional population/intervention/time/definition-specific materials
Further research
Proposal to distinguish the selected question from other conditions; no new investigation, calculation or trial was performed.
Remaining uncertainty
This record links preserved-summary statements; it does not establish external-paper comparison, a new efficacy verdict or completed content review.
Conditions for verification
Corresponding original materials and analysis scope for Other populations, durations/intensity and long-term follow-up beyond this question must be supplied so unverified matters can be distinguished. Preserved wording is linked here; existing content review remains incomplete.
Why this condition is needed
Preparation item distinguishing Other populations, durations/intensity and long-term follow-up beyond this question to link required and current materials for the selected question.
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Referenced methods
M03 §3.2.1–3.2.4; Dose, duration and effect-modification details are designed by CHAMGAP; M03 §3.2.4; CHAMGAP’s boundary for extensions; M03 §3.2.1; Detailed population criteria are designed by CHAMGAP; M03 §3.2.2–3.2.3; Reverse labels and test adaptations are designed by CHAMGAP

Related sources S01 S02

N26 · Original axes, Korean/English text, dates and corrections

Current findings
Subclaim C/note, parent D34, B/H/R1/I2/E0/B1/C0, false/true/false flags, empty overrides, Korean/English, 2026-08-26 and empty corrections/deliberation are preserved in the complete original summary.
Verification status
Partly verified
Materials actually read
Summary read; external material unread
Why unverified
Only the corresponding preserved-summary information is recorded; detailed originals remain unread and existing content review incomplete. Historical cross-checking/research accounts are not current review, original-paper reading or fulfillment of new conditions. Absent subclaim score/status/axes and parent facets keys are not filled. Existing content review remains incomplete.
Reason for missing information
Historical cross-checking/research accounts are not current review, original-paper reading or fulfillment of new conditions. Absent subclaim score/status/axes and parent facets keys are not filled.
Required materials and conditions
Distinction between original subclaim and parent values, original reference date and correction/history
Materials to obtain first
Original verdict, correction/change text and user comments
Further research
Updating proposal to distinguish changes to original materials from preparation versions; no new investigation, calculation or trial was performed.
Remaining uncertainty
This record links preserved-summary statements; it does not establish external-paper comparison, a new efficacy verdict or completed content review.
Conditions for verification
Corresponding original materials and analysis scope for Distinction between original subclaim and parent values, original reference date and correction/history must be supplied so unverified matters can be distinguished. Preserved wording is linked here; existing content review remains incomplete.
Why this condition is needed
Preparation item distinguishing Distinction between original subclaim and parent values, original reference date and correction/history to link required and current materials for the selected question.
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Referenced methods
M04 §4.5, §4.6.3; limits of this material conversion follow the review scope and internal design; M03 §3.1, §3.2.1–3.2.4 question-clarification principles; detailed separation rules are internally designed

Related sources S01 S02

N27 · Actual summary reading and unread external materials

Current findings
The preserved JSON summary was read for preparation, linking nine-year/24-month bibliographies and URLs. External papers, registration, protocol/SAP and funding/COI originals remain unread, with no access attempted.
Verification status
Partly verified
Materials actually read
Summary read; external material unread
Why unverified
Only the corresponding preserved-summary information is recorded; detailed originals remain unread and existing content review incomplete. Bibliographic links or registration identifiers do not upgrade acquisition/reading/review status. No external click/link checks were performed in this preparation. Existing content review remains incomplete.
Reason for missing information
Bibliographic links or registration identifiers do not upgrade acquisition/reading/review status. No external click/link checks were performed in this preparation.
Required materials and conditions
Actual reading by material, bibliography/URLs and additional-material gaps
Materials to obtain first
Original reports, registration/plans, disclosures and user comments
Further research
A research proposal for scope-specific updates based on actually acquired material; no new investigation, calculation or trial is performed in this conversion.
Remaining uncertainty
This record links preserved-summary statements; it does not establish external-paper comparison, a new efficacy verdict or completed content review.
Conditions for verification
Actual reading by material, bibliography/URLs and additional-material gaps: relevant original material and analysis scope must be provided with unverified matters distinguished. This conversion links preserved wording; existing content review remains incomplete.
Why this condition is needed
A production item distinguishing Actual reading by material, bibliography/URLs and additional-material gaps to connect the selected question’s needed material with current material.
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Referenced methods
M04 §4.5–4.6 material collection/selection principles; acquisition/reading separation and hyperlink specifications are internally designed; M04 §4.5, §4.6.3; limits of this material conversion follow the review scope and internal design

Related sources S01 S02